Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Nintedanib Plus EGFR TKI In EGFR-mutated Non-small Cell Lung Cancer Patients	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 1 / Phase 2	2025-01-23		NCT06071013

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
China Medical University Hospital	112
China Medical University, Taiwan	14

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
China Medical University Hospital	Taichung	Taiwan	54

Clinical trials